Report Overview
The global microplate reader market size was valued at USD 452.6 million in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 7.59% from 2023 to 2030. The adoption of microplate readers is fueled by the growth in the biotechnology sector and the increasing scope of applications in drug discovery and genomics and proteomics research. Furthermore, advantages offered by microplate readers over spectrophotometric devices, such as increased speed and efficiency in analytical workflows, and the availability of a broad range of reading functions are likely to boost the market growth.
The COVID-19 pandemic has increased the demand for point-of-care and rapid testing methods for disease surveillance and management of outbreaks. Furthermore, there has been an increase in the focus on the development of cost-effective, portable, and easy-to-use analytical devices, such as microplate readers, for supporting diagnostic testing activities. For instance, in November 2020, Enzo Biochem launched a portable microplate reader compatible with the company’s immunoassays and molecular diagnostic assays. As microwell plates are frequently used in enzyme-linked immunosorbent assays and molecular tests, such developments are expected to boost the demand for COVID-19-related offerings of microplate readers.
In addition, microplate readers are relatively maintenance-free and have a long life span. Although lamps are the most vulnerable components of microplate readers over the past few years, increasingly advanced options including deuterium, halogens, Xenon flash lamps, and LEDs have been introduced. Such developments have further increased the longevity of microplate readers, which is expected to increase the adoption of these instruments.
Moreover, detectors and associated detection methods for microplate readers have evolved to support high throughput screening and enable a faster turnaround time with high accuracy for drug screening applications. Hence, large volumes of drug compounds are now being processed with the help of assay miniaturization using microplate readers to reduce the costs of reagents required. Similarly, the integration of relevant analytical technologies with microplate systems is opening new avenues for market growth. For instance, in January 2020, Biotek Instruments, Inc. (Agilent Technologies, Inc.) launched its new Cytation 7 Cell Imaging Multi-Mode Reader that offers a combination of microscopy and multi-mode detection capabilities in a single instrument. Such innovations can enable the multipurpose use of microplate readers and boost the market growth in the near future.
Product Insights
Single-mode readers held the largest share of over 60.0% in 2022 due to their significant market penetration and established presence in various academic and industrial research and development settings. Moreover, these instruments are less expensive than multi-mode readers, and companies such as Biotek Instruments, Inc. (Agilent Technologies, Inc.), and Tecan Group Ltd. offer modular single-mode reader designs, which can be upgraded as required. In addition, single-mode readers are relatively easy to operate and are offered by a variety of manufacturers. As a result, the availability of a broad range of alternatives is anticipated to drive the segment.
The multi-mode readers segment is expected to expand at the fastest CAGR over the forecast period as manufacturers are focusing on offering greater flexibility and convenience of multi-modal instruments instead of several dedicated instruments. Moreover, along with fluorescence, absorbance, and luminescence analysis, multi-mode readers are offering various configurable modes for fluorescence resonance energy transfer, fluorescence polarization, amplified luminescent proximity homogeneous assays, and others. Such capabilities are likely to boost segment growth over the forecast period.
Application Insights
The drug discovery segment held the largest share of over 40.0% in 2022. This can be attributed to the broad range of applications of microplate reading devices in drug discovery processes. For instance, these instruments are used for automated detection and analysis of several labeled and label-free components while performing cell-based assays. Similarly, microplate readers offer high throughput capabilities by reading several wells simultaneously, and the throughput can be further increased with the help of automated robotic microplate stackers. Such technological capabilities are simplifying the use of advanced readers and are driving their adoption for drug discovery applications.
The genomics and proteomics research segment is expected to expand at a significant CAGR from 2023 to 2030 due to the availability of a variety of signal reading techniques for specific applications in genomics and proteomics. For instance, proteomics methods require the use of protein quantification methods such as Bradford, Lowry, or fluorescent assays, which can be easily performed using microplate-based AlphaScreen, fluorescence polarization, or time-resolved fluorescence energy transfer techniques. Moreover, the high demand for quantification of low concentrations of DNA for applications such as next-generation sequencing, SNP genotyping, and DNA methylation readout is likely to aid the revenue generation in this segment.
End-use Insights
Pharmaceutical and biotechnology companies and CROs dominated the market and accounted for a share of over 60.0% in 2022 due to the high commercial success of biopharmaceuticals and rapid growth in demand for CRO services. A significant increase in investments in the pharmaceutical industry has boosted drug screening activities for the discovery of novel therapeutics. Since microplate readers form an important aspect of drug screening and target identification and validation workflows, the demand for these instruments is expected to grow over the forecast period.
The academic and research institutions segment is expected to grow at a rapid pace from 2023 to 2030. The widespread availability of benchtop readers and technological advancements in sensitivity and accuracy of detection have accelerated the adoption of such instruments in academic and research institutions. Furthermore, the rising involvement of academic institutes in the development of novel biologics and the increase in funding opportunities for life sciences research are likely to raise the adoption of the technique in the coming years.
Regional Insights
North America held the largest share of over 40.0% in 2022 due to the presence of an established biopharmaceutical and CRO industry in the region and a high extent of R&D activities. Moreover, local presence of key companies such as Agilent Technologies, Inc.; Danaher Corporation; and PerkinElmer, Inc. is expected to drive the market in the region. Furthermore, increased infectious disease testing and high demand for ELISA-based tests in the region due to the COVID-19 pandemic have positively affected the market growth in North America.
The Asia Pacific region is projected to expand at the fastest CAGR from 2023 to 2030 due to the growing life sciences industry and rising interest of contract service providers in the region. Rapid economic development and high investments in research and development activities in emerging economies, such as China and India, are expanding the growth prospects for biotechnological research, which is anticipated to boost market growth.
Key Companies & Market Share Insights
The market is growing at a rapid pace due to various strategic initiatives adopted by key companies involved. For instance, in April 2022, Danaher Corporation launched the new SpectraMax Mini Multi-Mode reader consisting of a benchtop design suitable for academic laboratories. Some prominent players in the global microplate reader market include:
Danaher Corporation
Thermo Fisher Scientific, Inc.
BMG Labtech
PerkinElmer, Inc.
Promega Corporation
Bio-Rad Laboratories
Lonza
Agilent Technologies, Inc.
Enzo Life Sciences
Berthold Technologies GmbH & Co. KG